Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Joseph, G; Kelsey, RG; Peck, RW; Niwa, CG
   Response of some scolytids and their predators to ethanol and 4-allylanisole in pine forests of central Oregon
   JOURNAL OF CHEMICAL ECOLOGY
   
   G. Joseph et al., "Response of some scolytids and their predators to ethanol and 4-allylanisole in pine forests of central Oregon", J CHEM ECOL, 27(4), 2001, pp. 697-715
2. SEABER EJ; PECK RW; SMITH DA; ALLANSON J; HEFTING NR; VANLIER JJ; SOLLIE FAE; WEMER J; JONKMAN JHG
   THE ABSOLUTE BIOAVAILABILITY AND EFFECT OF FOOD ON THE PHARMACOKINETICS OF ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS
   British journal of clinical pharmacology
   
   E.J. Seaber et al., "THE ABSOLUTE BIOAVAILABILITY AND EFFECT OF FOOD ON THE PHARMACOKINETICS OF ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS", British journal of clinical pharmacology, 46(5), 1998, pp. 433-439
3. PECK RW; WOOTTON R; WIGGS R; LAYTON G; POSNER J
   EFFECT OF FOOD AND GENDER ON THE PHARMACOKINETICS OF TUCARESOL IN HEALTHY-VOLUNTEERS
   British journal of clinical pharmacology
   
   R.W. Peck et al., "EFFECT OF FOOD AND GENDER ON THE PHARMACOKINETICS OF TUCARESOL IN HEALTHY-VOLUNTEERS", British journal of clinical pharmacology, 46(1), 1998, pp. 83-86
4. SOULLAWTON JH; WEATHERLEY BC; POSNER J; LAYTON G; PECK RW
   LACK OF INTERACTION BETWEEN VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, AND DIGOXIN
   British journal of clinical pharmacology
   
   J.H. Soullawton et al., "LACK OF INTERACTION BETWEEN VALACICLOVIR, THE L-VALYL ESTER OF ACYCLOVIR, AND DIGOXIN", British journal of clinical pharmacology, 45(1), 1998, pp. 87-89
5. PECK RW; SEABER EJ; DIXON RM; LAYTON GR; WEATHERLEY BC; JACKSON SHD; ROLAN PE; POSNER J
   THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/
   Clinical pharmacology and therapeutics
   
   R.W. Peck et al., "THE PHARMACODYNAMICS AND PHARMACOKINETICS OF THE 5HT(1B 1D)-AGONIST ZOLMITRIPTAN IN HEALTHY-YOUNG AND ELDERLY MEN AND WOMEN/", Clinical pharmacology and therapeutics, 63(3), 1998, pp. 342-353
6. VERONESE L; GILLOTIN C; MARIONGALLOIS R; WEATHERLEY BC; THEBAULT JJ; GUILLAUME M; PECK RW
   LACK OF INTERACTION BETWEEN ORAL DIHYDROERGOTAMINE AND THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS
   Clinical drug investigation
   
   L. Veronese et al., "LACK OF INTERACTION BETWEEN ORAL DIHYDROERGOTAMINE AND THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN IN HEALTHY-VOLUNTEERS", Clinical drug investigation, 14(3), 1997, pp. 217-220
7. GILLOTIN C; BAGNIS C; MAMET JP; PECK RW; DERAY G
   NO NEED TO ADJUST THE DOSE OF 311C90 (ZOLMITRIPTAN), A NOVEL ANTIMIGRAINE TREATMENT, IN PATIENTS WITH RENAL-FAILURE NOT REQUIRING DIALYSIS
   International journal of clinical pharmacology and therapeutics
   
   C. Gillotin et al., "NO NEED TO ADJUST THE DOSE OF 311C90 (ZOLMITRIPTAN), A NOVEL ANTIMIGRAINE TREATMENT, IN PATIENTS WITH RENAL-FAILURE NOT REQUIRING DIALYSIS", International journal of clinical pharmacology and therapeutics, 35(11), 1997, pp. 522-526
8. PECK RW; SEABER EJ; DIXON R; GILLOTIN CG; WEATHERLEY BC; LAYTON G; POSNER J
   THE INTERACTION BETWEEN PROPRANOLOL AND THE NOVEL ANTIMIGRAINE AGENT ZOLMITRIPTAN (311C90)
   British journal of clinical pharmacology
   
   R.W. Peck et al., "THE INTERACTION BETWEEN PROPRANOLOL AND THE NOVEL ANTIMIGRAINE AGENT ZOLMITRIPTAN (311C90)", British journal of clinical pharmacology, 44(6), 1997, pp. 595-599
9. SEABER E; ON N; DIXON RM; GIBBENS M; LEAVENS WJ; LIPTROT J; CHITTICK G; POSNER J; ROLAN PE; PECK RW
   THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90)
   British journal of clinical pharmacology
   
   E. Seaber et al., "THE ABSOLUTE BIOAVAILABILITY AND METABOLIC DISPOSITION OF THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (311C90)", British journal of clinical pharmacology, 43(6), 1997, pp. 579-587
10. DIXON R; GILLOTIN C; GIBBENS M; POSNER J; PECK RW
    THE PHARMACOKINETICS AND EFFECTS ON BLOOD-PRESSURE OF MULTIPLE DOSES OF THE NOVEL ANTIMIGRAINE DRUG ZOLMITRIPTAN (311C90) IN HEALTHY-VOLUNTEERS
    British journal of clinical pharmacology
    
    R. Dixon et al., "THE PHARMACOKINETICS AND EFFECTS ON BLOOD-PRESSURE OF MULTIPLE DOSES OF THE NOVEL ANTIMIGRAINE DRUG ZOLMITRIPTAN (311C90) IN HEALTHY-VOLUNTEERS", British journal of clinical pharmacology, 43(3), 1997, pp. 273-281
11. SEABER EJ; RIDOUT G; LAYTON G; POSNER J; PECK RW
    THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (ZOMIG 311C90) HAS NO CLINICALLY SIGNIFICANT INTERACTIONS WITH PARACETAMOL OR METOCLOPRAMIDE
    European Journal of Clinical Pharmacology
    
    E.J. Seaber et al., "THE NOVEL ANTIMIGRAINE COMPOUND ZOLMITRIPTAN (ZOMIG 311C90) HAS NO CLINICALLY SIGNIFICANT INTERACTIONS WITH PARACETAMOL OR METOCLOPRAMIDE", European Journal of Clinical Pharmacology, 53(3-4), 1997, pp. 229-234
12. PECK RW; EQUIHUAMARTINEZ A; ROSS DW
    SEASONAL FLIGHT PATTERNS OF BARK AND AMBROSIA BEETLES (COLEOPTERA, SCOLYTIDAE) IN NORTHEASTERN OREGON
    The Pan-Pacific entomologist
    
    R.W. Peck et al., "SEASONAL FLIGHT PATTERNS OF BARK AND AMBROSIA BEETLES (COLEOPTERA, SCOLYTIDAE) IN NORTHEASTERN OREGON", The Pan-Pacific entomologist, 73(4), 1997, pp. 204-212
13. LEROY F; GODIN M; LEGALLICLER B; FILLASTRE JP; BIDAULT R; POSNER J; PECK RW
    PHARMACOKINETICS OF NETIVUDINE IN HEMODIALYSIS-PATIENTS
    Journal of antimicrobial chemotherapy
    
    F. Leroy et al., "PHARMACOKINETICS OF NETIVUDINE IN HEMODIALYSIS-PATIENTS", Journal of antimicrobial chemotherapy, 38(5), 1996, pp. 913-915
14. FILLASTRE JP; GODIN M; LEGALLICIER B; CHRETIEN P; BIDAULT R; GILLOTIN C; WOOTON R; POSNER J; PECK RW
    PHARMACOKINETICS OF NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS DRUG, IN PATIENTS WITH RENAL IMPAIRMENT
    Journal of antimicrobial chemotherapy
    
    J.P. Fillastre et al., "PHARMACOKINETICS OF NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS DRUG, IN PATIENTS WITH RENAL IMPAIRMENT", Journal of antimicrobial chemotherapy, 37(5), 1996, pp. 965-974
15. PECK RW; CROME P; WOOD MJ; MCKENDRICK MW; BANNISTER B; MANDAL BK; CROOKS RJ
    MULTIPLE-DOSE NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS AGENT,IN HEALTHY ELDERLY VOLUNTEERS AND PATIENTS WITH SHINGLES
    Journal of antimicrobial chemotherapy
    
    R.W. Peck et al., "MULTIPLE-DOSE NETIVUDINE, A POTENT ANTI-VARICELLA ZOSTER VIRUS AGENT,IN HEALTHY ELDERLY VOLUNTEERS AND PATIENTS WITH SHINGLES", Journal of antimicrobial chemotherapy, 37(3), 1996, pp. 583-597
16. PECK RW; WOOTTON R; LEE DR; JACKSON SHD; POSNER J
    THE BIOAVAILABILITY AND DISPOSITION OF 1-(BETA-D-ARABINOFURANOSYL)-5-(1-PROPYNYL)URACIL (882C87), A POTENT, NEW ANTI-VARICELLA ZOSTER VIRUSAGENT
    British journal of clinical pharmacology
    
    R.W. Peck et al., "THE BIOAVAILABILITY AND DISPOSITION OF 1-(BETA-D-ARABINOFURANOSYL)-5-(1-PROPYNYL)URACIL (882C87), A POTENT, NEW ANTI-VARICELLA ZOSTER VIRUSAGENT", British journal of clinical pharmacology, 39(2), 1995, pp. 143-149
17. PECK RW; WEATHERLEY BC; WOOTTON R; CROME P; HOLDICH TAH; POSNER J
    PHARMACOKINETICS AND TOLERABILITY OF SINGLE ORAL DOSES OF 882C87, A POTENT, NEW ANTI-VARICELLA-ZOSTER VIRUS AGENT, IN HEALTHY-VOLUNTEERS
    Antimicrobial agents and chemotherapy
    
    R.W. Peck et al., "PHARMACOKINETICS AND TOLERABILITY OF SINGLE ORAL DOSES OF 882C87, A POTENT, NEW ANTI-VARICELLA-ZOSTER VIRUS AGENT, IN HEALTHY-VOLUNTEERS", Antimicrobial agents and chemotherapy, 39(1), 1995, pp. 20-27
18. PECK RW; WIGGS R; POSNER J
    THE TOLERABILITY, PHARMACOKINETICS AND LACK OF EFFECT ON PLASMA-CHOLESTEROL OF 447C88, AN ACYLCOA-CHOLESTEROL-ACYL-TRANSFERASE (ACAT) INHIBITOR WITH LOW BIOAVAILABILITY, IN HEALTHY-VOLUNTEERS
    European Journal of Clinical Pharmacology
    
    R.W. Peck et al., "THE TOLERABILITY, PHARMACOKINETICS AND LACK OF EFFECT ON PLASMA-CHOLESTEROL OF 447C88, AN ACYLCOA-CHOLESTEROL-ACYL-TRANSFERASE (ACAT) INHIBITOR WITH LOW BIOAVAILABILITY, IN HEALTHY-VOLUNTEERS", European Journal of Clinical Pharmacology, 49(3), 1995, pp. 243-249
19. ROLAN PE; MERCER AJ; WEATHERLEY BC; HOLDICH T; MEIRE H; PECK RW; RIDOUT G; POSNER J
    EXAMINATION OF SOME FACTORS RESPONSIBLE FOR A FOOD-INDUCED INCREASE IN ABSORPTION OF ATOVAQUONE
    British journal of clinical pharmacology
    
    P.E. Rolan et al., "EXAMINATION OF SOME FACTORS RESPONSIBLE FOR A FOOD-INDUCED INCREASE IN ABSORPTION OF ATOVAQUONE", British journal of clinical pharmacology, 37(1), 1994, pp. 13-20
20. WOOD MJ; MCKENDRICK MW; BANNISTER B; MANDAL BK; PECK RW; CROOKS RJ
    PRELIMINARY PHARMACOKINETICS AND SAFETY OF 882C87 IN PATIENTS WITH HERPES-ZOSTER
    Journal of medical virology
    
    M.J. Wood et al., "PRELIMINARY PHARMACOKINETICS AND SAFETY OF 882C87 IN PATIENTS WITH HERPES-ZOSTER", Journal of medical virology, 1993, pp. 154-157